Wang Jialu, Liu Meitong, Zhao Jiuhan, Hu Pan, Gao Lianbo, Tian Shen, Zhang Jin, Liu Huayan, Xu Xiaoxue, He Zhenwei
Department of Neurology, First Affiliated Hospital of China Medical University, No.155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning, China.
Key Laboratory of Neurological Disease Big Data of Liaoning Province, No.155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning, China.
Biol Res. 2025 Jan 27;58(1):7. doi: 10.1186/s40659-025-00585-7.
Parkinson's disease (PD) is a progressive age-related neurodegenerative disease whose annual incidence is increasing as populations continue to age. Although its pathogenesis has not been fully elucidated, oxidative stress has been shown to play an important role in promoting the occurrence and development of the disease. Long noncoding RNAs (lncRNAs), which are more than 200 nucleotides in length, are also involved in the pathogenesis of PD at the transcriptional level via epigenetic regulation, or at the post-transcriptional level by participating in physiological processes, including aggregation of the α-synuclein, mitochondrial dysfunction, oxidative stress, calcium stabilization, and neuroinflammation. LncRNAs and oxidative stress are correlated during neurodegenerative processes: oxidative stress affects the expression of multiple lncRNAs, while lncRNAs regulate many genes involved in oxidative stress responses. Oxidative stress and lncRNAs also affect other processes associated with neurodegeneration, including mitochondrial dysfunction and increased neuroinflammation that lead to neuronal death. Therefore, modulating the levels of specific lncRNAs may alleviate pathological oxidative damage and have neuroprotective effects. This review discusses the general mechanisms of oxidative stress, pathological mechanism underlying the role of oxidative stress in the pathogenesis of PD, and teases out the mechanisms through which lncRNAs regulate oxidative stress during PD pathogenesis, as well as identifies the possible neuroprotective mechanisms of lncRNAs. Reviewing published studies will help us further understand the mechanisms underlying the role of lncRNAs in the oxidative stress process in PD and to identify potential therapeutic strategies for PD.
帕金森病(PD)是一种与年龄相关的进行性神经退行性疾病,随着人口持续老龄化,其年发病率正在上升。尽管其发病机制尚未完全阐明,但氧化应激已被证明在促进该疾病的发生和发展中起重要作用。长度超过200个核苷酸的长链非编码RNA(lncRNAs)也通过表观遗传调控在转录水平或通过参与包括α-突触核蛋白聚集、线粒体功能障碍、氧化应激、钙稳态和神经炎症在内的生理过程在转录后水平参与PD的发病机制。在神经退行性过程中,lncRNAs与氧化应激相关:氧化应激影响多种lncRNAs的表达,而lncRNAs调节许多参与氧化应激反应的基因。氧化应激和lncRNAs还影响与神经退行性变相关的其他过程,包括导致神经元死亡的线粒体功能障碍和神经炎症增加。因此,调节特定lncRNAs的水平可能减轻病理性氧化损伤并具有神经保护作用。本综述讨论了氧化应激的一般机制、氧化应激在PD发病机制中作用的病理机制,梳理了lncRNAs在PD发病机制中调节氧化应激的机制,并确定了lncRNAs可能的神经保护机制。回顾已发表的研究将有助于我们进一步了解lncRNAs在PD氧化应激过程中作用的机制,并确定PD的潜在治疗策略。